FundedIQ
Energy

Yanara

Yanara is a renewable energy company that builds, owns, and operates utility scale hybrid power plants.

www.yanarapower.com Amsterdam, The Netherlands 101-250 employees
Total raised
$171M
Rounds
1
Latest
Series Unknown
Jul 2026

Yanara is a renewable energy company that builds, owns, and operates utility scale hybrid power plants.

Yanara has raised $171M across 1 round. Its most recent round was a Series Unknown of $171M in Jul 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with FundedIQ

1 round on record.

Date
Round
Amount
Lead investor
Jul 21, 2026
Series Unknown
$171M

Unlock the lead investor and full details for this round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Yanara is featured in

Similar companies

Ore Energy

Ore Energy develops long-duration energy storage systems for renewable energy applications and electric power grids.

Series A $43.0M
Tempress Systems

Tempress Systems, Inc. develops and manufactures horizontal and vertical diffusion/atmospheric and low pressure chemical vapor deposition

Private Equity $22.9M
Promptwatch

Get your brand mentioned by AI search engines.

Seed $6.8M
Nopan

Nopan is a specialized Payment Service Provider built to optimize European account-to-account and digital wallet payments.

Seed $8.2M
Aardaia

Aardaia is leading the way in a new era of domestication on demand.

Seed $5.7M
ProQR Therapeutics

ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.

Series Unknown $59.2M
UniQure

uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. Gene therapy offers the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration. Our first product, Glybera, was approved by the European Commission in October 2012 under exceptional circumstances for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD, a potentially life-threatening, orphan metabolic disease. We are also developing a pipeline of additional adeno-associated virus (AAV)-based gene therapies through multiple collaborations. We develop our gene therapies using our innovative, modular technology platform, including our proprietary manufacturing process. We initially are focused on orphan diseases but believe that we will also be able to develop gene therapies targeting chronic and degenerative diseases that affect larger populations.

Series Unknown $259M
Droppie

Droppie is a recycling company that makes recycling easy and more accessible for consumers. The app is designed to help consumers recycle more effectively by offering small rewards for their recycled materials.

Seed $4.8M
Schunk Xycarb Technology

Schunk Xycarb Technology develops and manufactures high-tech quartz, ceramic, and graphite consumable parts utilized in semiconductor wafer processing equipment. The company provides specialized engineering and coating services to help global chipmakers optimize performance during advanced manufacturing processes.

Series Unknown $3.9M
Vertoro

Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and fuels.

Series B $11.5M
Vivici

Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers.

Series Unknown $11.5M
OurMind

OurMind is a HealthTech startup that builds generative AI tools to automate administrative and clinical workflows for healthcare professionals. Its flagship software captures real-time doctor-patient conversations across 90 languages and instantly converts them into structured medical notes. Built by medical providers and co-owned by dozens of specialists, the platform saves clinicians roughly 2 to 3 hours of paperwork daily to combat industry-wide burnout.

Seed $2.4M
14-day free trial · Cancel anytime

Know who just raised. Then know who to call.

Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.